These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2646619)

  • 1. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
    Carter BL; Gersema LM; Williams GO; Schabold K
    Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
    Vandongen R; Beilin LJ; Lalor C; Wall BP
    Aust N Z J Med; 1982 Oct; 12(5):473-7. PubMed ID: 6758744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients.
    Khan AU
    J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension.
    Douglas-Jones AP
    J Int Med Res; 1979; 7(3):221-3. PubMed ID: 378731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
    Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
    Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
    Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
    Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of Half-Inderal LA and Inderal LA in the treatment of hypertension in elderly subjects.
    Datta SR
    Br J Clin Pract; 1989 Mar; 43(3):102-8. PubMed ID: 2692687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
    Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
    Kubik MM; Hanks GW
    Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
    Kubik MM; Gill B; Dawes PM
    Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring.
    Rustin MH; Coomes EN
    Postgrad Med J; 1983 Dec; 59(698):770-4. PubMed ID: 6686326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.
    Oh VM; Chia BL; Taylor EA
    Br J Clin Pharmacol; 1985 Aug; 20(2):144-7. PubMed ID: 4041332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilevalol compared with propranolol and placebo for systemic hypertension.
    Schoenberger JA; Frishman WH; Wallin JD; Gorwit J; Davidov ME; Michelson EL; Bedsole GD; Cubbon J; Poland MP
    Am J Cardiol; 1989 Jun; 63(19):45I-49I. PubMed ID: 2658529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
    Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
    Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sustained-release clonidine and long-acting propranolol in the treatment of hypertension.
    Rodrigues E; Lawson AA
    Curr Med Res Opin; 1982; 8(4):274-81. PubMed ID: 6759060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.